COLORADO MEDTECH INC
S-8, 1999-01-19
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: PUTNAM NEW YORK TAX EXEMPT INCOME TRUST, N-30D, 1999-01-19
Next: CIPRICO INC, SC 13G/A, 1999-01-19



<PAGE>

   As filed with the Securities and Exchange Commission on January 19, 1998
                                                  SEC Registration No. _________


                          SECURITIES AND EXCHANGE COMMISSION
                                WASHINGTON, D.C. 20549

                                ----------------------

                                       FORM S-8
                                REGISTRATION STATEMENT
                           UNDER THE SECURITIES ACT OF 1933

                                ----------------------

                                COLORADO MEDTECH, INC.
                ------------------------------------------------------
                (Exact name of registrant as specified in its charter)


          Colorado                                           84-0731006
  -------------------------                              -------------------
   (State or other juris-                                  (IRS Employer    
  diction of incorporation)                              Identification No.)

                                 6175 Longbow Drive 
                               Boulder, Colorado 80301
                          -------------------------------
                          (Address of Principal Executive
                            Offices, including Zip Code)


                       COLORADO MEDTECH, INC. STOCK OPTION PLAN
                                  DIRECTOR WARRANTS
                ------------------------------------------------------
                               (Full title of the plan)

                                  Bruce L. Arfmann
                               COLORADO MEDTECH, INC.
                                 6175 Longbow Drive
                               Boulder, Colorado 80301
                                    (303) 530-2660
                  -------------------------------------------------
                  (Name, address, including zip code, and telephone
                  number, including area code of agent for service)

                                      Copies to
                                      ---------
                             Christopher M. Hazlitt, Esq.
                           Chrisman, Bynum & Johnson, P.C.
                                1900 Fifteenth Street
                                  Boulder, CO  80302
                                    (303) 546-1300

                                ----------------------

<PAGE>

                           CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
                                        Proposed            Proposed maximum
                         Amount         maximum             aggregate             Amount of
Title of securities      to be          offering price      offering              registration
to be registered         registered     per share (1)       price (1)             fee
<S>                      <C>            <C>                 <C>                   <C>

Common Stock
(no par value)            1,785,000        $11.44            $20,420,400           $6,024.02

</TABLE>

(1)  Estimated solely for the purpose of calculating the registration fee. 
Computed pursuant to Rule 457(c) using the average of the high and low prices 
for the Registrant's Common Stock as quoted on the Nasdaq Stock Market System 
on January 13, 1999.

<PAGE>

This Registration Statement registers an aggregate amount of 1,785,000 shares 
of the no par value common stock ("Common Stock") of Colorado MEDtech, Inc. 
(the "Company").  The shares of Common Stock registered are as follows: (i) 
an additional 1,500,000 shares pursuant to the Colorado MEDtech, Inc. Stock 
Option Plan (the "Option Plan"); and (ii) an additional 285,000 shares 
pursuant to warrants issued to directors of the Company.  The Option Plan was 
approved by the Board of Directors on June 25, 1992, and an increase in the 
number of shares of Common Stock available for grants under the Option Plan 
from 2,000,000 to 3,500,000 was approved by the Company's shareholders on 
November 21, 1997.

                              INCORPORATION BY REFERENCE

Pursuant to General Instruction E to Form S-8, the contents of the 
Registration Statement filed by the Company under Registration Statement No. 
333-17207, with respect to securities registered thereunder, are hereby 
incorporated by reference herein, and the opinions and consents listed below 
are annexed hereto:

<TABLE>
<CAPTION>
Exhibit No.    Description of Exhibit
<S>            <C>

5.1            Opinion of Chrisman, Bynum & Johnson, P.C. 

23.1           Consent of Chrisman, Bynum & Johnson, P.C. (included in 
               Exhibit 5.1).

23.2           Consent of Arthur Andersen LLP. 

24.1           Power of Attorney (included in the signature page of 
               original filing)

</TABLE>

                                       2

<PAGE>
                                      SIGNATURES


     Pursuant to the requirements of the Securities Act of 1933, the 
Registrant certifies that it has reasonable grounds to believe that it meets 
all of the requirements for filing on Form S-8 and has duly caused this 
Registration Statement to be signed on its behalf by the undersigned, 
thereunto duly authorized, in the City of Boulder, State of Colorado, on the 
15 day of January, 1999.


                                       COLORADO MEDTECH, INC.

                                       By: /s/ John V. Atanasoff
                                          -------------------------------
                                          John V. Atanasoff II, President


                                  POWER OF ATTORNEY

     KNOW ALL MEN BY THESE PRESENTS, that each person whose signature appears 
below constitutes and appoints John V. Atanasoff, II, Bruce L. Arfmann, or 
either of them, his or her true and lawful attorney-in-fact and agent, with 
full powers of substitution and resubstitution, for him or her and in his or 
her name, place and stead, in any and all capacities, to sign any and all 
amendments to this Registration Statement, including post-effective 
amendments, and to file the same, with all exhibits thereto, and other 
documents in connection therewith, with the Securities and Exchange 
Commission, granting unto said attorneys-in-fact and agents, full power and 
authority to do and perform each and every act and thing requisite and 
necessary to be done in and about the premises, as fully to all intents and 
purposes as he or she might or could do in person, and hereby ratifies and 
confirms all his or her said attorneys-in-fact and agents, or their 
substitute or substitutes, may lawfully do or cause to be done by virtue 
thereof. 

     Pursuant to the requirements of the Securities Act of 1933, this 
Registration Statement has been signed by the following persons in the 
capacities and on the dates indicated.


SIGNATURE                          TITLE                             DATE
- ---------                          -----                             ----


/s/ John V. Atanasoff         Chief Executive Officer,          January 14, 1999
- ---------------------         President and Director
John V. Atanasoff II          (Principal Executive Officer)


/s/ Bruce L. Arfmann          Senior Vice President,            January 14, 1999
- ---------------------         Chief Financial Officer, 
Bruce L. Arfmann              Secretary, Treasurer
                              (Principal Financial and
                              Accounting Officer)


/s/ Ira M. Langenthal         Director                          January 14, 1999
- ---------------------         
Ira M. Langenthal


                              Director                          January __, 1999
- ---------------------         
Dean A. Leffingwell

                                       3

<PAGE>


/s/ Clifford W. Mezey         Director                          January 14, 1999
- ---------------------         
Clifford W. Mezey


/s/ Robert L. Sullivan        Director                          January 14, 1999
- ---------------------         
Robert L. Sullivan


/s/ John E. Wolfe             Director                          January 14, 1999
- ---------------------         
John E. Wolfe


                                       4
<PAGE>

                                    EXHIBIT INDEX

<TABLE>
<CAPTION>
                                                                        Sequential
                                                                           Page
Exhibit No.    Description of Exhibit                                     Number
<S>            <C>                                                       <C>

5.1            Opinion of Chrisman, Bynum & Johnson, P.C. 

23.1           Consent of Chrisman, Bynum & Johnson, P.C. (included 
               in Exhibit 5.1).

23.2           Consent of Arthur Andersen LLP. 

24.1           Power of Attorney (included in the signature page of 
               original filing)

</TABLE>

                                       5

<PAGE>

January 19, 1999


Colorado MEDtech, Inc.
6175 Longbow Drive 
Boulder, CO  80301

Ladies and Gentlemen:

We have acted as counsel to Colorado MEDtech, Inc. (the "Company") in 
connection with the preparation and filing of a Registration Statement on 
Form S-8 ("Registration Statement") covering registration under the 
Securities Act of 1933 of 1,785,000 shares of the Company's Common Stock, no 
par value per share ("Shares").  The Shares to be registered are as follows: 
(i) an additional 1,500,000 shares pursuant to the Colorado MEDtech, Inc. 
Stock Option Plan;  and (ii) an additional 285,000 shares pursuant to 
warrants issued to directors of the Company.  The above-referenced plans and 
instruments pursuant to which the Shares are offered are referred to 
collectively herein as the "Offering Documents."  As such, we have examined 
the Registration Statement, the Company's Articles of Incorporation, as 
amended, its Bylaws and minutes of meetings of its Board of Directors.

Based upon the foregoing, we are of the opinion that, upon issuance of the 
Shares, each in accordance with the terms of the respective Offering 
Documents, the Shares will be validly issued, fully paid and nonassessable 
shares of Common Stock of the Company.

We consent to the use of this opinion as an exhibit to the Registration 
Statement and to the references to our firm in the Prospectus which is made a 
part of the Registration Statement.


Very truly yours,

/s/ Chrisman, Bynum & Johnson, P.C.

CHRISMAN, BYNUM & JOHNSON, P.C.

<PAGE>

                     CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

As independent public accountants, we hereby consent to the incorporation by 
reference in this registration statement on Form S-8 of our report dated 
August 24, 1998 included in the company's Form 10-K for the year ended June 30, 
1998 and to all references to our Firm included in this registration 
statement on Form S-8.

                                       ARTHUR ANDERSEN LLP


Denver, Colorado
 January 13, 1999


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission